Weihong Xu

机构：National Cancer Institute · ORCID：0000-0002-3988-3571

发表论文 85 篇 · 总被引 20617 次 · h-index 35

代表论文

• Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (2018 · New England Journal of Medicine · 被引 2324)
• A multiprotein supercomplex controlling oncogenic signalling in lymphoma (2018 · Nature · 被引 413)
• Extensive germline genome engineering in pigs (2020 · Nature Biomedical Engineering · 被引 168)
• Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma (2018 · Cancer Cell · 被引 127)
• Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma (2016 · Proceedings of the National Academy of Sciences · 被引 74)
• Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma (2024 · New England Journal of Medicine · 被引 73)